Healthcare
fromInvesting.com South Africa
4 days agoEarnings call transcript: Kiniksa Pharmaceuticals beats Q1 2026 forecasts By Investing.com
Kiniksa Pharmaceuticals delivered Q1 2026 results that beat EPS and revenue forecasts, driving a 21.51% stock surge and raised full-year guidance.